- Home
- REVG vs KZR Comparison
REVG vs KZR Comparison
Compare REVG & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVG
- KZR
- Stock Information
- Founded
- REVG 2008
- KZR 2015
- Country
- REVG United States
- KZR United States
- Employees
- REVG 5700
- KZR N/A
- Industry
- REVG Auto Manufacturing
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- REVG Consumer Discretionary
- KZR Health Care
- Exchange
- REVG Nasdaq
- KZR Nasdaq
- Market Cap
- REVG 2.9B
- KZR 29.7M
- IPO Year
- REVG 2017
- KZR 2018
- Fundamental
- Price
- REVG $59.16
- KZR $3.74
- Analyst Decision
- REVG Hold
- KZR Hold
- Analyst Count
- REVG 4
- KZR 2
- Target Price
- REVG $53.00
- KZR $9.00
- AVG Volume (30 Days)
- REVG 1.0M
- KZR 30.5K
- Earning Date
- REVG 09-03-2025
- KZR 11-11-2025
- Dividend Yield
- REVG 0.40%
- KZR N/A
- EPS Growth
- REVG N/A
- KZR N/A
- EPS
- REVG 2.12
- KZR N/A
- Revenue
- REVG $2,397,000,000.00
- KZR N/A
- Revenue This Year
- REVG $3.10
- KZR N/A
- Revenue Next Year
- REVG $7.86
- KZR N/A
- P/E Ratio
- REVG $28.17
- KZR N/A
- Revenue Growth
- REVG N/A
- KZR N/A
- 52 Week Low
- REVG $25.76
- KZR $3.62
- 52 Week High
- REVG $64.47
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- REVG 58.06
- KZR 35.98
- Support Level
- REVG $58.55
- KZR $3.76
- Resistance Level
- REVG $64.47
- KZR $4.05
- Average True Range (ATR)
- REVG 2.47
- KZR 0.13
- MACD
- REVG -0.16
- KZR -0.01
- Stochastic Oscillator
- REVG 59.68
- KZR 6.82
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.